FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A traumatic brain injury (TBI) can cripple patients for the rest of their lives, but new research suggests that many people with moderate-to-severe TBI have better-than-expected long-term outcomes. The findings show that decisions about halting life-sustaining treatment for these patients should not beContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — To do their best, Olympic athletes need to be both physically and mentally fit, but the COVID-19 pandemic and its restrictions at the Tokyo Olympics has made that a real challenge, experts say. “This Olympics is unprecedented,” said Dr. Michael Lardon, an associateContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — A proposed $26 billion settlement on opioid-related lawsuits has been reached with four large drug companies, a group of state attorneys general announced Wednesday. If enough states sign on to the deal with the country’s three major drug distributors — Cardinal Health, AmerisourceBergenContinue Reading